We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current SNDX market cap is 1.46B. The company's latest EPS is USD -2.4527 and P/E is -6.96.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 3.5M | 12.5M |
| Operating Income | -56.36M | -77.91M | -79.51M | -74.22M | -89.58M |
| Net Income | -51.15M | -72.47M | -72.4M | -68.06M | -84.13M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.52M | 1.52M | 139.71M | 0 | 0 |
| Operating Income | -57.54M | -71.42M | 26.22M | -151.76M | -229.95M |
| Net Income | -56.05M | -73.16M | 24.93M | -149.34M | -209.36M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 399.22M | 612.88M | 543.03M | 476.95M | 425.81M |
| Total Liabilities | 40.04M | 58.68M | 51.14M | 42.61M | 59.38M |
| Total Equity | 359.19M | 554.2M | 491.89M | 434.34M | 366.43M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 63.53M | 300.61M | 449.66M | 497.24M | 612.88M |
| Total Liabilities | 31.93M | 48.43M | 41.29M | 29.79M | 58.68M |
| Total Equity | 31.6M | 252.19M | 408.37M | 467.45M | 554.2M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -119.25M | -160.6M | -83.55M | -155.19M | -217.52M |
| Investing | 133.9M | 117.61M | -99.4M | -37.65M | 49.2M |
| Financing | 5.65M | 264.13M | 2.17M | 2.84M | 5.94M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -50.61M | -71.26M | 29.13M | -133.68M | -160.6M |
| Investing | 12.78M | -142.53M | -40.87M | -186.19M | 117.61M |
| Financing | 28.57M | 304.42M | 118.46M | 172.25M | 264.13M |
| Market Cap | 1.46B |
| Price to Earnings Ratio | -6.96 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4.93 |
| Price to Book Ratio | 2.63 |
| Dividend Yield | - |
| Shares Outstanding | 85.36M |
| Average Volume (1 week) | 1.07M |
| Average Volume (1 Month) | 2.45M |
| 52 Week Change | 2.90% |
| 52 Week High | 25.34 |
| 52 Week Low | 15.00 |
| Spread (Intraday) | 0.02 (0.12%) |
| Company Name | Syndax Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.syndax.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
